The unified social credit code/registration number of Chongqing Hanxin Pharmaceutical Co., Ltd. is 9150010862 2038564j, and the enterprise is in the state of opening.
The business scope of Chongqing Hanxin Pharmaceutical Co., Ltd. is: wholesale of chemical raw materials and their preparations, antibiotic raw materials and their preparations, biochemical drugs, Chinese patent medicines, biological products and toxic drugs for medical use (botulinum toxin A); Wholesale: Class II and Class III medical devices; General freight, special cargo transportation (refrigeration). (engage in business according to the matters and time limit approved by the license). Storage services (excluding dangerous chemicals); Business information consultation; Health management consultation (excluding diagnosis and treatment activities); Enterprise management consulting; Enterprise marketing planning; Market research; Hospital management (excluding medical activities and drug sales) (not allowed to engage in business without filing with the State Administration for Industry and Commerce). (Projects subject to approval according to law can only be operated after approval by relevant departments). In Chongqing, the total registered capital of companies with similar business scope is 53,893110,000 yuan, and the main capital is concentrated in enterprises with a scale of over 50 million and1-50 million, with 1.85. In the province, the registered capital of enterprises is good at present.
Chongqing Hanxin Pharmaceutical Co., Ltd. invested in 1 company with 0 branches.
See more information and materials of Chongqing Hanxin Pharmaceutical Co., Ltd. through Baidu Enterprise Credit.